Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of rivaroxaban with enoxaparin in fractures
IRCT20190305042931N1Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- May 2019
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of rivaroxaban and enoxaparin in venous thromboembolism (VTE) and thromboembolism (2 arms), sponsored by Arak University of Medical Sciences. Started May 2019; status: completed.
02
Drugs
rivaroxabanenoxaparin
03
Conditions
venous thromboembolism (VTE)thromboembolism
Beyond the preview
Go deeper on IRCT20190305042931N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190305042931N1.